Visual Symptoms of Wet AMD – What You Need to Know About Very Early Signs of AMD
Produced in collaboration with the American Macular Degeneration Foundation (AMDF).
Supported by an educational grant from Genentech, a member of the Roche Group
Join a panel of ophthalmologists, optometrists, and patients for a 1-hour free interactive presentation: Age-Related Macular Degeneration: Engaging in Care to Enhance Early Diagnosis and Access to Effective Treatment. The expert panel will discuss the risk factors for wet AMD, how to recognize the early signs of AMD, and strategies to minimize risks and delay progression. They review current effective treatments, as well as emerging treatment options and delivery systems. The experts will advise on how to work with your eye doctor to create a treatment plan that meets your needs and ensures the best possible outcomes.
Other topics that are explored:
- Clinical symptoms of AMD
- Home tests and technology to ensure early detection
- The stages of AMD and subclinical AMD
- VEGF inhibitors
- Emerging treatments and delivery devices
- Who administers medications for AMD?
- Strategies to maintain quality of life and independence with AMD
- Importance of routine monitoring
Effective Treatments Exist – and More Are Coming
What Role Do I Play? Working with Your Eye Doctor for the Best Possible Outcomes
Dante Pieramici, MD
Immediate Past Chair, AOA Contact Lens Cornea Section Diplomate, American Board of Optometry Vision Source Medical Director, Chicago Director, Professional Eye Care Center, Inc.
Dante Pieramici, MD, is the Director of the California Retina Research Foundation, a partner of the California Retina Consultants, and serves on the leadership board of the Retina Consultants of America. Dr. Pieramici has published over 125 peer reviewed papers, 16 book chapters, and has edited 3 books on retinal diseases. His research interests include clinical and basic science projects aimed at a better understanding of the underlying pathophysiology of ocular diseases, to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Senior Honor Award from the American Society of Retinal Specialists.
Grants, Advocacy and Partnerships Director, American Macular Degeneration Foundation
Matthew Levine is the grants, advocacy, and partnerships director of the American Macular Degeneration Foundation (AMDF) in Northampton, Massachusetts. For the past 18 years, his professional career has been in the nonprofit, vision research grantmaking community, working with thought leaders and researchers to advance solutions for those affected by vision loss and blindness. Previously, at Research to Prevent Blindness, Inc., Matthew directed marketing and communications activities accompanying the distribution of more than $120 million to vision researchers. He has worked with chairs of departments of ophthalmology, research directors, scientists, and colleagues at other foundations to develop programs that empower those affected by loss-of-sight to lead fulfilling lives.
Pamela Lowe, OD, FAAO, Dipl. ABO
Director, California Retina Research Foundation Partner, California Retina Consultants Member, Retina Consultants of America
Patient with AMD